v3 Template
N

Nura Bio

Biotechnology/Healthcare ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$68.0M
Funding Rounds
1
Last Funding
2024-09-17

About Nura Bio

Nura Bio envisions a world where neurological disorders are met with hope for a cure. The company aims to halt neurological diseases by targeting fundamental pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity.

Products & Services

Neuroprotective Therapies:Therapies focused on altering the course of neurological diseases through targeting axon degeneration and neuroimmune regulation.

Specialties

Neurological Disease Treatment Axon Degeneration Research Neuroimmune Regulation Neuroprotective Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 68000000
MR: -
FA: $68 Million
FAN: 68000000 		D: 2024-09-17
FD: 2024-09-17 		4 investors
Series A Latest
2024-09-17
$68.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Shilpa Sambashivan

Chief Executive Officer

L

Lahar Mehta

Chief Medical Officer

S

Scott Greenberg

Chief Business Officer

T

Tim Kutzkey

Managing Partner at The Column Group

S

Sanjay Keswani

President & CEO

M

Mark Goldsmith

Founding President, CEO and Board Chairman

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Nura Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~150 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro